Ralph Kern - Mar 6, 2022 Form 4 Insider Report for BRAINSTORM CELL THERAPEUTICS INC. (BCLI)

Role
COO and Chief Medical Officer
Signature
/s/ Ralph Kern
Stock symbol
BCLI
Transactions as of
Mar 6, 2022
Transactions value $
$0
Form type
4
Date filed
3/14/2022, 08:00 PM
Previous filing
Dec 10, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BCLI Common Stock Award $0 +35.9K +19.15% $0.00 223K Mar 6, 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares acquired are shares of restricted stock awarded under the Issuer's 2014 Stock Incentive Plan. The shares of restricted stock vest as to 25% of the award on each of the first, second, third and fourth anniversary of March 6, 2022, provided that the Reporting Person remains continuously employed by the Company from the date of grant through each applicable vesting date.